EP Patent

EP1956023A1 — Method for lithium exchange reactions

Assigned to Lonza AG · Expires 2008-08-13 · 18y expired

What this patent protects

The present invention relates to a process for lithium exchange reactions comprising mixing at least two fluids in a microreactor having at least two injection points.

USPTO Abstract

The present invention relates to a process for lithium exchange reactions comprising mixing at least two fluids in a microreactor having at least two injection points.

Drugs covered by this patent

Invokana (CANAGLIFLOZIN) · Johnson & Johnson

Patent Metadata

Patent number: EP1956023A1
Jurisdiction: EP
Classification: —
Expires: 2008-08-13
Drug substance claim: No
Drug product claim: No
Assignee: Lonza AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.